Yahoo Canada Web Search

Search results

  1. Jun 26, 2024 · This session, with Jack Kavanaugh, MSW '15, Executive Director of GLYS WNY, will help identify strategies to advocate for and support the LGBTQ+ youth in your lives, both personal and professional, and build a stronger support network for young people to find themselves.

  2. Jun 26, 2024 · This session, with Jack Kavanaugh, MSW '15, Executive Director of GLYS WNY, will help identify strategies to advocate for and support the LGBTQ+ youth in your lives, both personal and professional, and build a stronger support network for young people to find themselves.

  3. 5 days ago · "We've spent more than seven years diligently creating new materials to improve battery storage capacity and safety and are now moving into a new phase of production at industry-level scale," commented Jack Kavanaugh, Nanotech Energy’s CEO and co-founder.

    • Ivan Shumkov
  4. 2 days ago · Nanotech Energy is a developer of graphene products with applications in batteries, transparent conducting electrodes, conductive inks, printed electronics, conductive epoxy, antistatic coatings and EMI (electromagnetic interference) shielding. The company was founded by Jack Kavanaugh, Maher El-Kady, and Richard Kaner in 2014 and is ...

  5. Jun 26, 2024 · This session, with Jack Kavanaugh, MS '15, Executive Director of GLYS WNY, will help identify strategies to advocate for and support the LGBTQ+ youth in your lives, both personal and professional, and build a stronger support network for young people to find themselves.

    • Jack Kavanaugh1
    • Jack Kavanaugh2
    • Jack Kavanaugh3
    • Jack Kavanaugh4
    • Jack Kavanaugh5
  6. Jun 9, 2024 · GLYS of Western New York, which works with LGBTQ+ youth, has distributed tassels to area high school graduates for at least five to 10 years, Executive Director Jack Kavanaugh said. The ...

  7. People also ask

  8. 5 days ago · LOS ANGELES--(BUSINESS WIRE)--Dr. Jack Kavanaugh, Chairman of Novonco Pharmaceuticals, Inc., announced today that Novonco has licensed the exclusive rights to City of Hope’s novel anti-cancer agent COH29, a potential breakthrough agent in the fight against hard-to-treat cancers, including ovarian cancer.